Look Who it Was Random video

Kalyan Handique | My Entrepreneurial Journey

1,269 views · Published 22 May 2015 · 40:26 · Indexed 31 October 2026

Channel: Michigan Engineering · 2015 · Science & Technology

Watch on YouTube

You are invited to join the University of Michigan Department of Chemical Engineering at the fourth annual Chemical Engineering Graduate Symposium, where we will highlight and celebrate the research of current graduate students through both oral and poster presentations. 
For this year's keynote address Dr. Kalyan Handique will discuss his career path of starting a medical device startup company during the final stages of his Ph.D., growing and exiting the company; a brief stint at a very large company and going back to the exciting life of another startup. Dr. Handique will try to highlight the key differences between working at a startup vs. a big company, the extreme learning you would expect  at an early startup as well as point out the work-life balancing issues you would expect at a startup.
Biography:
Dr. Kalyan Handique is currently the President and Chief Executive Officer of DeNovo Sciences, Inc. DeNovo Sciences is bringing cutting-edge circulating tumor cell detection technology to the cancer research and clinical markets. Kalyan co-founded HandyLab, a start-up molecular diagnostic company, in 2000 while earning his Ph.D. in Chemical Engineering at the University of Michigan. He played a pivotal role in forming the vision and the core technical team for HandyLab, as well as in conceiving the positive, vibrant culture of the company. He served as the company's CTO and board member. Under his leadership, the highly motivated HandyLab team successfully launched a series of integrated molecular diagnostic products in the hospital testing market. In 2009, Becton Dickinson (BD) Diagnostic systems acquired HandyLab in a landmark deal valued at more than $275 million. Kalyan briefly served as the Vice President of R&D Systems Development at BD. In addition, Kalyan serves as a board of director of other life sciences startups such as 3D Biomatrix and PhasiQ and as an advisor to seed-stage venture funds such as Zell Lurie Commercialization Fund and Augment Ventures. Kalyan is also the author of numerous journal articles in prestigious publications such as Science, and is a prolific inventor with more than 70 patents and patent applications to his credit.

More from this channel